Search
for
Sort by
Research 211–240 of 995
- The Link Between Obesity and the Skin
- Analyzing the Efficacy of Isotretinoin in Treating Dissecting Cellulitis: A Literature Review and Meta-Analysis
- Zinc in dermatology
- Skin disease related to metabolic syndrome in women
- Incidence of skin diseases diagnosed in a public institution: comparison between 2003 and 2014
- Common Dermatologic Disorders in Down Syndrome: Systematic Review
- Alexithymia and Cutaneous Disease Morbidity: A Systematic Review
- Genetically predicted levels of circulating cytokines and the risk of six immune skin diseases: a two-sample Mendelian randomization study
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Cardiovascular Disease-Associated Skin Conditions
- Spironolactone in dermatology: uses in acne and beyond
- Metabolism and skin diseases
- Three cases of androgen‐dependent disease associated with myotonic dystrophy
- A Review of the Most Common Dermatologic Conditions and their Debilitating Psychosocial Impacts
- Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- Off-Label Use of Botulinum Toxin in Dermatology—Current State of the Art
- Preparing the hair follicle canal for hair shaft emergence
- Folliculitis decalvans managed with adalimumab: A case report
- Could Vaccination against COVID-19 Trigger Immune-Mediated Inflammatory Diseases?
- Trace element zinc and skin disorders
- Spironolactone in dermatology
- Metabolic Syndrome and Skin Disease: Potential Connection and Risk
- Viewpoint 6
- Abstracts
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- Assessing the burden of dermatological diseases on work life from a gender perspective
- Off-label dermatologic uses of IL-23 inhibitors
- Evidence of a Causal Relationship Between Body Mass Index and Immune-Mediated and Inflammatory Skin Diseases and Biomarkers: A Mendelian Randomization Study
- Medical Dermatology